Strategy & Management

Magazine articles on business strategy, management and leadership.

Old Articles: <Older 4591-4600 Newer>

BusinessWeek May 9, 2005 Brian Hindo	GM's Ace in the Hole: Cash For all of the problems General Motors faces, liquidity isn't one of them. Reserves of at least $45 billion help the carmaker keep its credit rating above junk and give it some flexibility to maneuver. One of those moves could be selling off parts if the company.
BusinessWeek May 9, 2005	10 Turning Points for GM From a massive downsizing to disastrous marketing, General Motors has made some painful missteps over the recent past. Here's a look back at some key developments in its downturn.
BusinessWeek May 9, 2005	The BusinessWeek Best-Seller List Suze Orman's 'The Money Book for the Young, Fabulous & Broke' is giving Malcolm Gladwell's 'Blink' a race for the hardcover top-spot. And James E. Neal Jr.'s popular paperback 'Effective Phrases for Performance Appraisals' is a just month away from the long-running best-seller category.
BusinessWeek May 9, 2005 Catherine Arnst	Genentech's Lessons For Big Pharma The biotech company focuses on science -- not marketing, acquisitions, or patents.
BusinessWeek May 9, 2005 Peter Coy	This Big Oil Deal Shouldn't Hurt A Bit Valero's bid for Premcor looks like it would actually be consumer-friendly.
BusinessWeek May 9, 2005 Olga Kharif	Taking Video Games To The Next Level Cell-phone game sales are hot -- sparking deals and the interest of big game makers.
IndustryWeek May 1, 2005 Traci Purdum	Teaming, Take 2 Teaming today is one of the fundamentals of manufacturing, especially in a global economy. However, the key to success lies in how teams are implemented.
InternetNews April 28, 2005 Michael Singer	Intergraph Merges Divisions Information technology service provider Intergraph is undergoing a reorganization intended to more adequately reflect its plan for growth.
The Motley Fool April 28, 2005 Tom Taulli	Book Review: "The Baron Son" Lessons come from this business book wrapped in a story by Vicky T. Davis, William R. Patterson, and D. Marques Patton.
The Motley Fool April 28, 2005 Brian Gorman	PPD Branches Out The company, which concentrates on running clinical trials for pharmaceutical and biotech clients is right in diversifying, but its strategy carries its own risk.
<Older 4591-4600 Newer> Return to current articles.